Someone you care about is unwell, and you want to be useful. You can look through what’s recruiting in Canada, keep what seems worth a second look, and send it to them or their doctor in one message.
Whether they follow any of it up is theirs to decide.
As you look, keep the trials that seem worth a second look. When you’re ready, they go to the person you’re thinking of — or to their doctor — as one plain-language note, in your words. Nothing is sent until you say so.
Whether they read it, or do anything with it, is entirely theirs. You don’t need their details to do any of this.
Not sure how to bring it up? A few things worth knowing first →
Explore this study →
There are 4 groups in this study. Groups A and C, the comparison group, receive VIM0423. Groups B and D, the placebo group, receive VIM0423 Placebo.
One site, in Toronto
Official title: A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
PARKINSON DISEASE (Disorder) · Vima Therapeutics
Get them matched to the best-fit trials
Answer a few questions and we'll find the closest matches.
Looking for the closest fit?
Get matched →Whether or not the results above are what you were looking for, someone at Concord can search with you.
Concord provides information only. Trial listings come from public registries, and whether anyone can take part is decided by the trial site and their own care team.